Allogeneic Cell Therapy

NEW YORK, August 6, 2026 MiNK Therapeutics announced that it will report its second-quarter 2026 financial results before U.S....

OSLO, Norway, July 13, 2026 Zelluna announced that the first patient has been dosed in the ZIMA-101 Phase 1...

HOUSTON, July 7, 2026 FibroBiologics, Inc. has announced the successful completion of the third manufacturing batch of its investigational...

PRINCETON, N.J., June 1, 2026 Made Scientific has been selected as the manufacturing partner for Columbia University’s NOVAKnee program,...

Seattle, WA; Cambridge, MA; Tokyo, Japan – May 6, 2026 Aurion Biotech, Inc. announced that it will deliver an...

December 21, 2025 | Beijing, China — T-MAXIMUM Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has...

San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...